Search - tctmd.com

Displaying 101 - 120 of 279

Sort: Relevancy | Date

Presentation TCT 2018

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Presenter: Fernando Alfonso, Azeem Latib, Antonio Colombo

September 22, 2018

Presentation TCT 2018

Case Study: Mechanism and Treatment of Stent Thrombosis

Presenter: Fernando Alfonso, Azeem Latib, Hiram G. Bezerra, Michael J. Cowley, Kevin J. Croce, Lisette Okkels Jensen, Ashish Pershad, Jose M. de la Torre Hernandez

September 22, 2018

Presentation TCT 2018

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Presenter: Fernando Alfonso, Azeem Latib, Robert A. Byrne

September 22, 2018

Presentation TCT 2018

Use and Outcomes With Drug-Coated Balloons in Patients With Lower Extremity Peripheral Artery Disease

Presenter: Lindsay S. Machan, Craig M. Walker, Schuyler Jones

September 22, 2018

Presentation TCT 2018

EffPac-RCT: A Randomized Trial Evaluating a Drug-Coated Balloon in Superficial Femoral and Popliteal Arteries

Presenter: Lindsay S. Machan, Craig M. Walker, Marcus Thieme

September 22, 2018

Presentation TCT 2018

IN.PACT DCB: Pooled Multistudy Assessment of Drug-Coated Balloon Treatment for Femoropopliteal Peripheral Artery Disease

Presenter: Lindsay S. Machan, Craig M. Walker, Mehdi H. Shishehbor

September 22, 2018

Presentation TCT 2018

TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population

Presenter: Sunil V. Rao, Patrick W. Serruys

September 22, 2018

Presentation TCT 2018

SORT OUT IX: A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent in an All-Comers Patient Population

Presenter: Sunil V. Rao, Lisette Okkels Jensen

September 22, 2018

Presentation TCT 2018

LEADERS FREE II: Evaluation of a Polymer-Free Coronary Drug-Eluting Stent in High Bleeding-Risk Patients With One-Month Dual Antiplatelet Therapy

Presenter: Mitchell W. Krucoff

September 22, 2018

News Conference News TCT 2018

The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent

Yael L. Maxwell

September 22, 2018

Presentation TCT 2018

ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent in an All-Comers Patient Population

Presenter: Gregg W. Stone, Pieter R. Stella

September 22, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Shelley Wood

September 22, 2018

Presentation TCT 2018

BIONYX: A Randomized Trial Evaluating a Thin Composite Wire Strut Durable Polymer-Based DES Compared with an Ultra-Thin Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

Presenter: Gregg W. Stone, Clemens von Birgelen

September 22, 2018

Presentation TCT 2018

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

Presenter: William A. Gray

September 22, 2018

Presentation TCT 2018

TCT-3: The Lutonix® Global Drug Coated Balloon Registry Real World Patients With Below the Knee Disease Interim 12 Month Outcomes

Presenter: Steven R. Bailey, Patrick W. Serruys, Steve Henao

September 22, 2018

Presentation TCT 2018

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Sorin J. Brener

September 22, 2018

Presentation TCT 2018

Ultra-Thin Strut DES: A Meaningful Advance?

Presenter: Renu Virmani, Clemens von Birgelen, Sripal Bangalore

September 22, 2018

Presentation TCT 2018

Can Contemporary DES Be Improved by Altering the Drug, Polymer, Alloy or Construction?

Presenter: Renu Virmani, Clemens von Birgelen, David E. Kandzari

September 22, 2018

Presentation TCT 2018

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Presenter: Renu Virmani, Clemens von Birgelen, Michael Joner

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

Advertisement

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Case Study: Mechanism and Treatment of Stent Thrombosis

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Use and Outcomes With Drug-Coated Balloons in Patients With Lower Extremity Peripheral Artery Disease

EffPac-RCT: A Randomized Trial Evaluating a Drug-Coated Balloon in Superficial Femoral and Popliteal Arteries

IN.PACT DCB: Pooled Multistudy Assessment of Drug-Coated Balloon Treatment for Femoropopliteal Peripheral Artery Disease

TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population

SORT OUT IX: A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent in an All-Comers Patient Population

LEADERS FREE II: Evaluation of a Polymer-Free Coronary Drug-Eluting Stent in High Bleeding-Risk Patients With One-Month Dual Antiplatelet Therapy

The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent

ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent in an All-Comers Patient Population

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

BIONYX: A Randomized Trial Evaluating a Thin Composite Wire Strut Durable Polymer-Based DES Compared with an Ultra-Thin Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

TCT-3: The Lutonix® Global Drug Coated Balloon Registry Real World Patients With Below the Knee Disease Interim 12 Month Outcomes

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Ultra-Thin Strut DES: A Meaningful Advance?

Can Contemporary DES Be Improved by Altering the Drug, Polymer, Alloy or Construction?

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content